Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Asthma · Pharmacokinetics · AMPH

Amphastar France Pharmaceuticals

Amphastar France Pharmaceuticals clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga HQ
1996 Founded
46 Employees
Public company Type
AMPH · NYSE Ticker
Company details
Status
Public
HQ
USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
Founded
1996
Employees
46
Programs
18
Drugs
15
Patents
15
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Amphastar France Pharmaceuticals projects

18 ClinicalTrials.gov programs sponsored by Amphastar France Pharmaceuticals.

Amphastar France Pharmaceuticals has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

18 programs

Clinical programs

  1. Armstrong Albuterol Sulfate Inhalation Aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  2. E004 (Epinephrine Inhalation Aerosol) HFA-MDI

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  3. Epinephrine HFA-MDI (E004)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  4. I004

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    phase 3 small molecule active

    2 trials

  5. Placebo

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  6. albuterol (Armstrong Albuterol HFA)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  7. albuterol HFA (Armstrong's)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  8. epinephrine inhalation aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    2 trials

  9. A006

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  10. A006 DPI

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    2 trials

  11. API-E004-CL-A

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial

  12. API-E004-CL-B4

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial

  13. Albuterol DPI 25 mcg/inh

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  14. Arm T1: Primatene Mist HFA

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  15. Epinephrine Inhalation Aerosol, HFA

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  16. Hyaluronidase

    Amphastar France Pharmaceuticals

    Allergic Skin Reaction

    phase 2 small molecule completed

    1 trial

  17. albuterol inhalation powder

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  18. Epinephrine (0.125 mg/inhalation)

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    approved other completed

    1 trial

Frequently asked questions

How many clinical projects does Amphastar France Pharmaceuticals have?

18 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.